eli lilly trial retatrutide Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity Lilly shares safety, tolerability data

Nausea is the most common side effect, particularly during dose escalation

Medical Malpractice Claims Related to Prescribing, Lack of Informed Consent, Inadequate Monitoring, or Off-Label Use Individual lawsuits may also include medical malpractice claims against prescribing physicians or healthcare providers

Lawson MA, Parrott JM, McCusker RH, Dantzer R, Kelley KW, OConnor JC

In preclinical models, this translates to measurably faster healing of tendons, ligaments, muscles, and GI tissue

She adds that some long-term clinical trials have also demonstrated that a high protein diet can help protect against weight gain after weight loss, and with no real adverse effects on bone density or kidney function

Currently, taking glutathione is not contraindicated